Home
News
Create
Screeners
Insights
Aarey Drugs & Pharmaceuticals
66.
55
+3.74
(+5.95%)
Market Cap
₹188.70 Cr
PE Ratio
51.93
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+5.95%
1M
+0.20%
6M
-6.57%
1Y
+96.84%
5Y
+53.52%
View Company Insights
Latest news about Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals Reports Q3FY26 Results with Revenue Decline
Feb 11, 2026
Aarey Drugs & Pharmaceuticals Limited reported Q3FY26 results with revenue from operations declining 27.9% to ₹9,642.63 lakhs from ₹13,378.86 lakhs in Q3FY25. Net profit decreased 20.7% to ₹56.95 lakhs compared to ₹71.80 lakhs in the previous year quarter. Nine-month performance also showed declining trends with total income falling 21.4% to ₹28,932.32 lakhs and net profit dropping 16.6% to ₹296.49 lakhs. The company purchased fixed assets during the period that are not yet operational.
Aarey Drugs & Pharmaceuticals Announces Share Capital Increase and Preferential Issue Plans
Sep 06, 2025
Aarey Drugs & Pharmaceuticals Reports Q1 Results: Revenue Dips, Profit Rises
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO